BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.

Rheumatology (Oxford, England)

Volumn 47, Issue 6, 2008, Pages 924-925

  Chakravarty, K ^a   McDonald, H ^a   Pullar, T ^a   Taggart, A ^a   Chalmers, R ^a   Oliver, S ^a   Mooney, J ^a   Somerville, M ^a   Bosworth, A ^a   Kennedy, T ^a  

^a HAROLD WOOD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

ARTICLE; DRUG MONITORING; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL AUDIT; METHODOLOGY; PRACTICE GUIDELINE; PUBLIC RELATIONS; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG MONITORING; EVIDENCE-BASED MEDICINE; HUMANS; INTERPROFESSIONAL RELATIONS; MEDICAL AUDIT;

EID: 45849124232     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel216a     Document Type: Article

References (0)